BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 640817)

  • 1. Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.
    Enat R; Pollack S; Ben-Arieh Y; Livni E; Barzilai D
    Br Med J; 1980 Apr; 280(6219):982-3. PubMed ID: 7417768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute hepatitis caused by pyridinol carbamate].
    Grange JD; Mallet L; Barbare JC; Bodin F; Petite JP; Darnis F
    Gastroenterol Clin Biol; 1984 Feb; 8(2):194-5. PubMed ID: 6698356
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver damage induced by pyridinol carbamate.
    Litvin Y; Lubovsky E; Brezis M
    Lancet; 1977 Jun; 1(8024):1257. PubMed ID: 68350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pyridimocarbamate (prodectin)-induced acute liver damage, cirrhosis and primary liver cancer--accidental finding?].
    Kendrey G; Kiss F; László B
    Morphol Igazsagugyi Orv Sz; 1989 Jan; 29(1):51-4. PubMed ID: 2716753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hepatitis due to pyricarbate (Angioxine). Apropos of 5 cases].
    Biour M; Barbare JC; Begaud B; Furet Y; Grange JD; Cheymol G
    Therapie; 1984; 39(5):531-6. PubMed ID: 6506010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis from pyricarbate].
    Sée A; Bouvry M
    Gastroenterol Clin Biol; 1984; 8(6-7):579. PubMed ID: 6745580
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic injury due to pyridinol carbamate.
    Enat R; Barzilai D; Gellei B
    Isr J Med Sci; 1978 Mar; 14(3):333-8. PubMed ID: 640817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic granulomas: review of 73 patients from one hospital and survey of the literature.
    Irani SK; Dobbins WO
    J Clin Gastroenterol; 1979 Jun; 1(2):131-43. PubMed ID: 400661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Features of liver damage caused by 17-alpha-alkyl-substituted anabolic steroids].
    Lovisetto P; Mairano D; Actis GC; Marchi L
    Minerva Med; 1979 Mar; 70(11):769-90. PubMed ID: 372848
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of halothane on hepatic function.
    Little DM
    Clin Anesth; 1968; 1():85-137. PubMed ID: 4877408
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphologic spectrum of drug-induced hepatic disease.
    Ishak KG; Zimmerman HJ
    Gastroenterol Clin North Am; 1995 Dec; 24(4):759-86. PubMed ID: 8749898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-induced hepatic diseases].
    Biour M; Jaillon P
    Pathol Biol (Paris); 1999 Nov; 47(9):928-37. PubMed ID: 10609273
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.